GSK’s stock is currently trading at around 1,450p a share. The company is expected to report earnings tomorrow and looking at the chart, we can see the price has been falling since the rejection of an attempt to move higher on October 11^th. From a technical viewpoint, the bullish trend remains in place as the supportive trendline hasn’t been tested or broken as of yet. Support along the trendline reads 1,406p, so there still is room for additional pullbacks. However, a break below this support could see the price head lower towards 1,359p, potentially shifting some investor sentiment on the stock. Towards the upside, resistance sits at 1,460p (yesterday’s high) then at 1,471p and then at 1,495p. A break and close above 1,495p may see an extension towards 1,515p-1,520p. The earnings season has been a hit-and-miss so far amongst global markets, and the UK economy has also been the worst performer out of the G7 group. Hence, the risk right now is greater than usual. The technical indicators point towards a bearish approach as the MACD is negative and the RSI reads 43.